Robert Sullivan
Erchonia Lasers Ltd, UK
Title: Pre-diabetes management in obese patients using 635 nm of laser light to modify/correct the anticipated outcomes
Biography
Biography: Robert Sullivan
Abstract
Cold lasers have been used in weight management and body contouring for a many years, but as a modality, is often overlooked and misunderstood. Drawing on clinical evidence gathered over many years, it is possible to see how 635 nm laser can be used for the good of the patient and benefit or change their quality of life. A review and follow-up of 140 patients in a randomized double blind study investigating the efficacy of 635 nm lasers in the management of pre-diabetes patients, shows that 635 nm of light can reverse the anticipated clinical outcomes in 90% of patients reverse the anticipated clinical outcomes. The study presented here includes obese patients with pre-diabetes, aged between 40 and 65 year old. 50% of the patients received dietary advice and true laser and 50% received LED and dietary advice. This study represents a breakthrough in the treatment of pre-diabetes patients, using a modality usually used in the cosmetic industry. We have demonstrated in this study that laser can be an effective adjunct to conventional treatments in the obese pre-diabetes patient. 10% of the sham study patients as opposed to 90% of patients in the true laser group reduced their weight considerably over 10 weeks and 20 laser treatments and were no longer a diabetes risk (monitoring was advised).